Therapies
to treat cardiovascular risk differs - Doctors
Accra, May 20, Ghanadot/GNA - Therapies to treat cardiovascular risk events
differ depending on the age of an individual, and increases with age.
This observation was made by Professor Wolfgang Koenig of University of Ulm,
Germany, Professor James Shepherd, University of Glasgow, Scotland and
Professor Paul Ridker, Brigham and Women's Hospital, USA during an
educational event transmitted by Satellite link from Boston, USA to a global
audience and monitored in Accra on Tuesday.
It was on the theme "Extending the Boundaries of Cardiovascular Risk
Intervention - Optimising Assessment and Treatment".
The event was to address the need for effective therapeutic intervention to
reduce the risk of Cardio-Vascular (CV), recognise co-morbidities that raise
the risk of CV and additional risk factors not included in traditional risk
assessment methods for effective treatment.
They noted that many factors contributed to an individual's risk of
developing CV, adding that compressive assessment and management of all risk
factors were important for optimal CV risk reduction.
They said the use of therapies was governed by guidelines but since
traditional assessment methods might underestimate CV risk, many individuals
at high risk of clinical events were not eligible for therapy under current
guidelines.
They therefore, called for proper management of CV risks to ensure the
individual's life was assured.
The live broadcast was sponsored by the management of AstraZeneca
Pharmaceuticals, a South African drugs manufacturing company, which apart
from manufacturing drugs also conducts research into medicines.
GNA
